Virology Testing Market - Size,
Opportunity Analysis, 2018 – 2026
Outlook,
and
Virology testing consist of diagnostic methods that help in early detection of the disease such as
hepatitis, influenza, HIV, sexually transmitted disease, RCV, and other viral associated disease.
Virology testing examines for detection of viral antigens, nucleic acids, and antibodies in the
given sample in order to confirm the presence of particular viral infection. There are more than
100 viral diseases identified.
Download PDF Brochure Of This Research Report @
https://www.coherentmarketinsights.com/insight/request-pdf/2037
In order to confirm viral infections, virology testing inculcates various methods. Culture medium
based method in which virus is confirmed by colony formation over culture has been
traditionally used since long time. Although this method is widely acceptable and easy to
perform, it is often time consuming, as it takes few days to weeks to confirm presence of
particular virus. It is a serious limitation especially in viral pandemics where loss of time could
result in more widespread infection and delay in management of the viral infection.
New advanced molecular based virology testing methods has been evolved in recent past such
as immunoassay, nucleic acid based amplification testing methods (PCR based methods), mass
spectrometry based detection methods and next generation genome sequencing methods, which
are accurate, quick, and provides result for diversified viral infections.
Virology Testing Market- Market Dynamics
Virology testing market is projected to witness significant growth during forecast period with
rising prevalence of virus originated diseases such as flu, hepatitis, AIDS, and STDs, Ebola,
Influenza based viral infections, severe acute respiratory syndrome from coronavirus,
hemorrhagic fever etc. across world. Early and fast diagnosis of virus infection is very essential
to start treatment course.
According to the World Health Organization (WHO), January 2018 factsheet, all types of
influenza in combination causes annual epidemics about 3 to 5 million cases with severe stage